Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

CYP2U1 Activators

CYP2U1 is a distinct member of the cytochrome P450 superfamily, enzymes known for their critical role in the metabolism of a wide array of substrates, including xenobiotic and endogenous compounds. The CYP2U1 enzyme is characterized by its specificity for hydroxylating fatty acids, particularly long-chain fatty acids, which underscores its unique position in metabolic processes. Its expression is noted across several tissues, with significant levels in the brain, thymus, and heart, suggesting a specialized function in the metabolism within these organs. The regulation of CYP2U1 expression is a complex interplay of genetic and environmental factors, which ensures that its activity is modulated in response to the body's metabolic demands. Understanding the elements that influence the expression of CYP2U1 is crucial, as they shed light on the broader regulatory networks that govern the metabolism of lipids and other important biological molecules.

A variety of chemical compounds have been identified as activators that could induce the expression of the CYP2U1 protein. These activators typically exert their effects through the activation of specific nuclear receptors or signaling pathways, which then lead to an increase in the transcription and subsequent expression of the CYP2U1 enzyme. For instance, certain agents that act as ligands for nuclear receptors such as the pregnane X receptor (PXR) and the constitutive androstane receptor (CAR) can prompt the upregulation of CYP2U1. Similarly, natural compounds or dietary elements that engage PPAR receptors, which play a pivotal role in lipid metabolism, may also induce the expression of this enzyme. Moreover, environmental factors, such as exposure to particular organic pollutants that activate the aryl hydrocarbon receptor (AhR), are known to stimulate the expression of various cytochrome P450 enzymes, including CYP2U1. These chemical activators are essential in understanding the adaptive responses of the body to a changing metabolic landscape, providing insights into the regulation of CYP2U1 and its role in maintaining physiological homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$97.00
$328.00
$676.00
$1467.00
6
(1)

Rifampicin is known to strongly stimulate P450 enzymes by activating the PXR, which might extend to an increase in CYP2U1 expression.

Carbamazepine

298-46-4sc-202518
sc-202518A
1 g
5 g
$33.00
$71.00
5
(0)

Carbamazepine may upregulate CYP2U1 through activation of both PXR and CAR, leading to enhanced transcription of various P450 enzymes.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

Omeprazole could stimulate the hepatic expression of CYP2U1 by activating the nuclear receptor CAR, which responds to chemical stimuli.

Clofibrate

637-07-0sc-200721
1 g
$33.00
(1)

Clofibrate is known to upregulate P450 enzymes through activation of PPARs, which may include the transcriptional activation of CYP2U1.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Dexamethasone can stimulate the expression of CYP2U1 by engaging glucocorticoid receptors, which can enhance the transcription of detoxifying enzymes.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Pioglitazone, through its action as a PPARγ agonist, could upregulate the transcription of CYP2U1, enhancing its enzymatic activity related to fatty acid metabolism.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

Rosiglitazone may stimulate the expression of CYP2U1 through PPARγ-dependent pathways, influencing lipid processing enzymes.